Key points are not available for this paper at this time.
The risk of PTC recurrence is mainly related to the presence of lymph node metastases and extrathyroidal invasion, whereas no impact of BRAF V600E mutation has been demonstrated.
Building similarity graph...
Analyzing shared references across papers
Loading...
Agnieszka Czarniecka
National Institute of Oncology
Monika Kowal
The Maria Sklodowska-Curie National Research Institute of Oncology
Dagmara Rusinek
National Institute of Oncology
SHILAP Revista de lepidopterología
PLoS ONE
The Maria Sklodowska-Curie National Research Institute of Oncology
Building similarity graph...
Analyzing shared references across papers
Loading...
Czarniecka et al. (Wed,) studied this question.
synapsesocial.com/papers/69dd67987dbdc4ad1440c8b2 — DOI: https://doi.org/10.1371/journal.pone.0132821